社区卫生工作者培训对痴呆症的影响:一项准实验性研究
Aline Cristina Ramos Coelho1, Edmir Batista da Silva Cruz1, Helena Zacharias Radicchi1
1Universidade Federal de São Paulo. Santos, São Paulo, Brazil.
Revista brasileira de enfermagem
|March 21, 2024
概括
社区卫生工作人员在培训研讨会后,表现出更好的痴呆症知识. 这种提高意识对于在初级保健机构早期发现痴呆症状至关重要.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 医学教育 医学教育
背景情况:
- 痴呆症是一个日益增长的全球健康挑战.
- 早期发现痴呆症对于及时干预和管理至关重要.
- 社区卫生工作者在初级保健和公共卫生推广方面发挥着至关重要的作用.
研究的目的:
- 评估一场关于社区卫生工作者对痴呆症知识的培训研讨会的影响.
- 评估培训在改善痴呆症迹象检测方面的有效性.
主要方法:
- 这是一项涉及33名社区卫生人员的准实验性研究.
- 使用阿尔茨海默病知识量表评估的知识,研讨会前后.
- 进行了10个每周在线同步培训课程.
主要成果:
- 研讨会后,阿尔茨海默病知识量表的平均得分从16.3增加到21.24.
- 观察到知识的显著改善为4.94分.
- 培训干预表明对痴呆症知识有积极影响.
结论:
- 社区卫生人员的持续教育对于痴呆症意识至关重要.
- 增强的知识有助于在初级保健中及时发现痴呆病例.
- 培训使代理人能够识别迹象并了解可修改的风险因素.
相关概念视频
Community Based Intervention
41
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
41
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184


